Menu

Daré Bioscience, Inc. DARE

Full chart Compare
Set alert

Price alert · DARE

All alert types
0.62 USD 0.00 (+0.08%)

Nov 6, 2026, 10:38 AM EST

0.6212 Day range 0.6355
0.61 52-week range 3.78
YTD
-67.64%
1 year
-65.50%

Revenue & Expenses

Other Income → Expenses: $153.06KExpenses → Gross Loss: $1.42MExpenses → Selling, General & Admin: $8.76MExpenses → Research & Development: $5.52BOther Operating Income → Expenses: $5.52BNet Loss → Expenses: $13.40MRevenue → Cost of Revenue: $1.03MOther Income$153.06KOther Operating Income$5.52BNet Loss$13.40MCost of Revenue$2.45MExpenses$5.53BGross Loss$1.42MSelling, General & Admin$8.76MResearch & Development$5.52BRevenue$1.03M

Latest period ending Dec 31, 2025 · select a line to chart its full history

DARE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.03M9.78K2.81M10.00M0
734.39K9.78K2.81M10.00M0
-13.55M-23.45M-30.94M-31.39M-39.07M
-13.40M-4.05M-30.16M-30.95M-38.70M
-1.20-0.48-4.15-4.44-7.60
DARE annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
24.71M15.70M11.64M34.68M51.67M
32.47M22.10M21.28M43.83M55.81M
29.63M28.11M26.33M32.71M17.05M
2.66M1.30M1.40M488.74K270.55K
2.84M-6.01M-5.05M11.11M38.75M
DARE annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-9.89M5.47M-38.86M-18.09M-28.76M
-385.28K-573.05K-629.43K-63.07K-14.52K
19.28M354.52K15.64M1.34M75.85M
-385.28K-573.05K-629.43K-63.07K-14.52K
9.01M5.19M-23.86M-17.00M47.00M